{"title":"Five-Gene Expression Formula Accurately Detects Hepatocellular Carcinoma Tumors","authors":"Aram Ansary Ogholbake, Qiang Cheng","doi":"10.1002/biot.70073","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Several diagnostic methods, such as imaging modalities and Serum Alpha-Fetoprotein (AFP) testing, have been used for HCC detection; however, their effectiveness is limited to later stages of the disease. In contrast, transcriptomic analysis of biopsy samples has shown promise for early detection. Although machine learning techniques have been applied to transcriptomic data for cancer detection, their clinical adoption remains limited due to challenges such as poor generalizability across different datasets, lack of interpretability, and high computational complexity. To address these limitations, we developed a novel predictive formula for HCC detection using the Kolmogorov–Arnold Network (KAN). This formula is based on the expression levels of five genes: VIPR1, CYP1A2, FCN3, ECM1, and LIFR. Derived from the GSE25097 dataset, the formula offers a simple, interpretable, efficient, and accessible approach for HCC identification. It achieves 99% accuracy on the GSE25097 test set and demonstrates robust performance on six additional independent datasets, achieving accuracies of above 90% in all cases. These findings highlight the critical role of these five genes as biomarkers for HCC detection, offering a foundation for future research and clinical applications to improve HCC diagnostic approaches.</p>\n </div>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"20 7","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/biot.70073","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Several diagnostic methods, such as imaging modalities and Serum Alpha-Fetoprotein (AFP) testing, have been used for HCC detection; however, their effectiveness is limited to later stages of the disease. In contrast, transcriptomic analysis of biopsy samples has shown promise for early detection. Although machine learning techniques have been applied to transcriptomic data for cancer detection, their clinical adoption remains limited due to challenges such as poor generalizability across different datasets, lack of interpretability, and high computational complexity. To address these limitations, we developed a novel predictive formula for HCC detection using the Kolmogorov–Arnold Network (KAN). This formula is based on the expression levels of five genes: VIPR1, CYP1A2, FCN3, ECM1, and LIFR. Derived from the GSE25097 dataset, the formula offers a simple, interpretable, efficient, and accessible approach for HCC identification. It achieves 99% accuracy on the GSE25097 test set and demonstrates robust performance on six additional independent datasets, achieving accuracies of above 90% in all cases. These findings highlight the critical role of these five genes as biomarkers for HCC detection, offering a foundation for future research and clinical applications to improve HCC diagnostic approaches.
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.